For the Inventor, By the Inventor

Enter assignee name

Basel, Switzerland

Dermavant Sciences Gmbh

USPTO Granted Patents = 21

% Expired Patents = 4.8

EPO Patents = 3

Trademarks = 8

Forward Citations = 37

Loading Chart...

Loading Chart...

29 inventors (with patents filed for the assignee):

Sujatha Sonti (6 out of 13 patents)

Jon Lenn (6 out of 7 patents)

Joey Roger Thomas (6 out of 6 patents)

4. Leandro Santos (6 out of 6 patents)

5. Justin Whiteman (6 out of 6 patents)

6. Michael Quinn Doherty (6 out of 7 patents)

7. Mary Bedard (6 out of 6 patents)

8. Piyush Jain (6 out of 6 patents)

9. Susan H Smith (5 out of 5 patents)

10. Channa K Jayawickreme (4 out of 4 patents)

11. Cunyu Zhang (4 out of 4 patents)

12. William Zuercher (4 out of 4 patents)

13. Ian Paul Andrews (4 out of 4 patents)

14. Nicholas Calandra (4 out of 4 patents)

15. Tyler Andrew Davis (4 out of 5 patents)

21 patents: Sort by Forward Citations

1. 12569453 - Use of tapinarof for the treatment of atopic dermatitis (2026-03-10),

2. 12275696 - Process for preparing tapinarof (2025-04-14),

3. 12252471 - Isoquinoline compounds and their use in treating AhR imbalance (2025-03-18),

4. 11938099 - Use of tapinarof for the treatment of atopic dermatitis (2024-03-26),

5. 11827605 - Isoquinoline compounds and their use in treating AhR imbalance (2023-11-28),

6. 11622945 - Topical pharmaceutical compositions (2023-04-11),

7. 11617724 - Topical pharmaceutical compositions (2023-04-04),

8. 11612573 - Topical pharmaceutical compositions (2023-03-28),

9. 11597692 - Process for preparing tapinarof (2023-03-07),

10. 11590088 - Use of Tapinarof for the treatment of chronic plaque psoriasis (2023-02-28),

11. 11548853 - Isoquinoline compounds and their use in treating AhR imbalance (2023-01-10),

12. 11497718 - Use of tapinarof for the treatment of atopic dermatitis (2022-11-15),

13. 11458108 - Topical pharmaceutical compositions (2022-10-04),

14. 11267788 - Isoquinoline compounds and their use in treating AhR imbalance (2022-03-08),

15. 10961175 - Process for preparing tapinarof (2021-03-30),

Dermavant Sciences GmbH is a biopharmaceutical company based in Basel, Switzerland, focused on developing innovative therapies for dermatological conditions. The organization specializes in advanced research and technology aimed at addressing unmet medical needs in skin health. With a commitment to improving patient outcomes, Dermavant leverages its expertise in drug development to create effective solutions for various skin disorders, emphasizing a patient-centric approach in its therapeutic advancements.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

21 Patents

#27 in Basel

#591 in Switzerland

#29,893 in the World

Basel, Switzerland

Dermavant Sciences Gmbh

Forward Citations = 37

29 inventors:

Sujatha Sonti (6 out of 13 patents)

Jon Lenn (6 out of 7 patents)

Joey Roger Thomas (6 out of 6 patents)

4. Leandro Santos (6 out of 6 patents)

5. Justin Whiteman (6 out of 6 patents)

Please report any incorrect information to [email protected]

Loading…